Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
3(100.0%)
3Total
Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03726307Phase 1Active Not Recruiting

Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study

Role: lead

NCT03164265Phase 1Completed

DCreg in Living Donor Liver Transplantation

Role: lead

NCT04208919Phase 1Active Not Recruiting

Delayed Infusion of DCreg in Living Donor Liver Transplantation

Role: lead

All 3 trials loaded